Action of thyrotropin-releasing hormone in experimental hemorrhagic shock — cardiovascular mechanism

Abstract

Thyrotropin-releasing hormone (TRH) could improve mean arterial pressure (MAP), myocardial contractile parameters (±dp/dt_max, V_pm and V_max) and increase plasma epinephrine level significantly at 10 min after TRH administration in hemorrhagic shock rabbits, but the action of TRH on MAP and the myocardial contractility did not appear in rabbits pre-treated with reserpine (4 mg/kg, 24 h pre-treatment, i. v.). TRH had no effects on myocardial contractility and MAP at 20 and 30 min after administration to rabbits pre-treated with β-adrenergic Mocker propranolol (1 mg/kg, 1 h before TRH injection i.V.), but it did exert effects on these parameters in rabbits pre-treated with α-adrenergic blocker phenoxybenzamine. Experiments in vitro showed that, although TRH (10^-4M/L) had no direct effect on heart, left atrium and aortic strip, it did potentiate the inotropic effects of isoprenaline and dopamine on the left atrium. These results suggested that antishock effect of TRH is related to adrenergic system. TRH stimulates sympathomedullary system to secrete epinephrine and sensitize the β-receptors, but not α-receptors. Thus, TRH improves cardiac contractility, cardiac output and hemodynamics during hemorrhagic shock. The sensitization of the βand dopamine receptors played an important role in producing direct peripheral actions of TRH.

Keywords

thyrotropin-releasing hormone / hemorrhagic shock / cardiovascular function / adrenergic system

References

[1] TegaL, et al. . Beneficial effect of thyrotropin-releasing hormone in canine hemorrhagic shock. Circ Shock, 1987, 21: 51-7

[2] LeffewSD, et al. . Cardiorespiratory alterations produced by centrally admi-nistered thyrotropin-releasing hormone during canine endotoxic shock. Circ Shock, 1987, 21: 225-32

[3] 1988; 2(3):172–7.

[4] 1982:561–2.

[5] LevyJV.. ConfordEM. Isolated aterial preparations. Methods of Pharmacology, 1971, New York, Applenten Century Crofts: 77-104

[6] HoladayJW, et al. . Thyrotropin-releasing hormone improves cardiovasculars function in experimental endotoxic and hemorrhagic shock. Science, 1981, 213: 216-8

[7] LuxWE, et al. . Thyrotropin-releasing hormone reverses experimental anaphylactic shock through non-endorphin related mechanisms. Eur J Pharmacol, 1983, 90: 301-2

[8] McIntoshTK, et al. . Thyrotropin-releasing hormone and circulatory shock. Circ Shock, 1986, 18: 241-58

[9] SugiuraA, et al. . Thyrotropin-releasing hormone improves survival in canine hemorrhagic shock. J Surg Res, 1986, 40: 63-8

[10] TRH 1987;4:127–8.

[11] AmirS, et al. . Thyrotropin-releasing hormone (TRH) improved survival in anaphylactic shock: A central effect mediated by the sympatho-adrenomedullary beta-adrenoceptive system. Brain Res, 1984, 298: 219-24

[12] AmirS, et al. . Anti-anaphylactic action In the mouse of thyrotropin-releasing hormone (TRH) is mediated through betaadrenoceptive effects. Neurosci Lett, 1984, 46: 127-32

[13] HoladayJW, et al. . Thyrotropin-releasing hormone: Autonomic effects upon cardiorespiratory function in endotoxic shock. Reg Peptides, 1983, 7: 111-25

[14] MattilaJ, et al. . Sympathomimetic pressor responses to thyrotropin-releasing hormone in rats. Am J Physiol, 1986, 251: H86-92

[15] MattilaJ, et al. . Sympathetic vasocon-striction and renin secretion cause pressor responses to thyrotropin-releasing hormone in rats. J Pharmacol Exprt Ther, 1985, 238: 232-6

[16] KunosG, et al. . Thyrotropin-releasing hormone and naloxone attenuate the antihypertensive action of central alpha-2 adrenoceptor stimulation through different mechanisms. Endocrinology, 1984, 18: 2481-8

[17] HoladayJW, et al. . Thyrotropin-releasing hormone antagonizes beta endorphin hypothermia and catalepsy. Life Sci, 1978, 22: 1537-44

[18] DedhiaHV, et al. . Changes in plasma endorphins during therapy of canine hemorrhagic shock with thyrotropin-releasing hormone. Circ Shock, 1985, 16: 68-68

[19] LuxWE, et al. . Thyrotropin-releasing hormone reverses the hypotension and bradycardia produced by leukotriene D4 in unanesthetized guinea pigs. Prostaglandins Leuk Med, 1983, 10: 301-7

[20] FeuersteinG, et al. . Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. Circ Shock, 1984, 13: 255-60